First Turn Management LLC Sells 11,647 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Turn Management LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,254 shares of the medical equipment provider's stock after selling 11,647 shares during the period. Intuitive Surgical comprises about 2.4% of First Turn Management LLC's holdings, making the stock its 21st largest holding. First Turn Management LLC's holdings in Intuitive Surgical were worth $14,863,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the period. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock worth $25,000 after buying an additional 42 shares during the period. LGT Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 54 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter valued at about $33,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In related news, insider Jamie Samath sold 269 shares of the business's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. The trade was a 2.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now owns 821 shares in the company, valued at approximately $402,519.88. This represents a 35.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock valued at $45,897,071 in the last quarter. 0.80% of the stock is owned by insiders.

Intuitive Surgical Stock Up 1.4 %

Shares of NASDAQ ISRG traded up $7.18 on Tuesday, reaching $538.82. 1,118,896 shares of the company's stock traded hands, compared to its average volume of 1,458,894. The business's 50 day simple moving average is $500.33 and its two-hundred day simple moving average is $459.58. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $544.38. The company has a market cap of $191.92 billion, a price-to-earnings ratio of 86.31, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ISRG. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a "buy" rating in a research report on Friday, October 18th. Citigroup upped their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Raymond James upped their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Monday, October 14th. Finally, BTIG Research set a $535.00 target price on Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.